Figure 1. Total number of infections treated vs. confirmed with positive lab cultures. UTI: urinary tract infection; LegInf: leg infection; InfStSup: superficial surgical site infection.
| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website http://www.jocmr.org |
Original Article
Volume 9, Number 1, January 2017, pages 10-16
Hospital-Acquired Infections After Cardiac Surgery and Current Physician Practices: A Retrospective Cohort Study
Figures
Tables
| Characteristics | Infection cases | P value | |
|---|---|---|---|
| Yes, n = 39 (%) | No, n = 146 (%) | ||
| CABG: coronary artery bypass graft; CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; Cr: creatinine; CVD: cerebral vascular disease; EF: ejection fraction; Isol: isolated; NYHA: New York Heart Association; PVD: peripheral vascular disease; n/s: not significant. | |||
| Age (years) | 0.0185 | ||
| < 60 | 7 (17.9) | 54 (37.0) | |
| 60 - 69 | 12 (30.8) | 51 (34.9) | |
| 70 - 79 | 14 (35.9) | 23 (15.8) | |
| ≥ 80 | 6 (15.4) | 18 (12.3) | |
| Female | 7 (17.9) | 32 (21.9) | n/s |
| EF < 40% | 6 (15.4) | 14 (9.6) | n/s |
| PVD and/or CVD | 15 (38.5) | 47 (32.2) | n/s |
| Renal insufficiency (Cr > 176) | 4 (10.3) | 10 (6.8) | n/s |
| Diabetes | 13 (33.3) | 39 (26.7) | n/s |
| CHF | 5 (10.2) | 14 (9.6) | n/s |
| COPD | 7 (17.5) | 16 (11.0) | n/s |
| Redo surg. | 1 (2.6) | 11 (7.5) | n/s |
| Procedure type | n/s | ||
| Isol. CABG | 20 (51.3) | 76 (52.1) | |
| Isol. valve | 5 (12.8) | 29 (19.9) | |
| CABG + valve | 6 (15.4) | 10 (6.8) | |
| Complex procedure | 8 (20.5) | 31 (21.2) | |
| Status | n/s | ||
| Elective | 14 (35.9) | 76 (52.1) | |
| In-house | 22 (56.4) | 60 (41.1) | |
| Urgent (< 4 h) | 2 (5.1) | 7 (4.8) | |
| Emergency | 1 (2.6) | 3 (2.1) | |
| NYHA class | n/s | ||
| I | 1 (2.9) | 15 (12.3) | |
| II | 11 (32.4) | 39 (32.0) | |
| III | 19 (55.9) | 51 (41.9) | |
| IV | 3 (8.8) | 17 (13.9) | |
| Outcome | Infection cases | P value | |
|---|---|---|---|
| Yes, n = 39 (%) | No, n = 146 (%) | ||
| LOS: length of stay; sSSI: superficial surgical site infection; UTI: urinary tract infection. | |||
| Mortality | 4 (10.3) | 3 (2.1) | 0.0369 |
| LOS > 9 days | 28 (71.8) | 50 (34.2) | < 0.0001 |
| Infection type | |||
| UTI | 14 (35.9) | - | |
| Pneumonia | 12 (30.8) | - | |
| Leg harvest site | 9 (23.1) | - | |
| sSSI | 8 (20.5) | - | |
| Sepsis | 3 (7.7) | - | |
| Infection type | Organism | Cases |
|---|---|---|
| sSSI: superficial surgical site infection; UTI: urinary tract infection. | ||
| UTI | Escherichia coli | 7 |
| Pseudomomas aeruginosa | 2 | |
| Citrobacter youngae | 1 | |
| Serratia marcescens | 1 | |
| Candida albicans | 1 | |
| Klebsiella pneumoniae | 1 | |
| Morganella morganii | 1 | |
| Pneumonia | Haemophilus influenzae | 3 |
| Pseudomonas aeruginosa | 2 | |
| Escherichia coli | 1 | |
| Serratia marcescens | 1 | |
| Staphylococcus aureus | 1 | |
| Streptococcus pneumoniae | 1 | |
| Proteus vulgaris | 1 | |
| Enterobacter cloacae | 1 | |
| Leg harvest site | Cellulitis*** | 1 |
| sSSI | Coagulase-negative staphlococci | 2 |
| Sepsis | Candida albicans | 2 |
| Coagulase-negative staphlococci | 1 | |